A detailed history of Private Capital Group, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 14 shares of RGNX stock, worth $103. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Previous 14 -0.0%
Holding current value
$103
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 13, 2021

BUY
$29.09 - $45.68 $407 - $639
14 New
14 $1,000
Q3 2020

Nov 12, 2020

SELL
$27.01 - $40.26 $1,755 - $2,616
-65 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$27.75 - $43.44 $693 - $1,086
25 Added 62.5%
65 $2,000
Q1 2020

May 07, 2020

BUY
$21.5 - $54.2 $86 - $216
4 Added 11.11%
40 $1,000
Q4 2019

Feb 14, 2020

BUY
$34.54 - $44.87 $414 - $538
12 Added 50.0%
36 $1,000
Q3 2019

Nov 13, 2019

BUY
$31.84 - $50.88 $764 - $1,221
24 New
24 $1,000
Q2 2019

Aug 15, 2019

SELL
$42.0 - $59.29 $252 - $355
-6 Closed
0 $0
Q4 2018

Jan 28, 2019

BUY
$39.11 - $75.15 $234 - $450
6 New
6 $0

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $320M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.